Abstract:Abstract Macrophages can be divided into a classically (M1) or alternatively activated (M2) phenotype depending on the cytokine environment. Commonly, IFNg±LPS and IL-4±IL-13 drive the M1 and M2 phenotype, respectively. In humans however, understanding of the M1/M2 paradigm is still evolving. Recent findings also suggest that the growth factors GM-CSF and M-CSF influence human macrophage development towards a M1- or M2-like phenotype. We analyzed macrophages grown from human blood monocytes under GM-CSF or M-CSF culture conditions that were treated with either IFNg ± LPS or IL-4/IL-13. Cells were analyzed for the expression of genes associated with the M1 and M2 phenotype. To further explore mechanisms defining the M1/M2 cells, superarray was performed to evaluate mRNA differences in the expression of chromatin modifying enzymes. In both GM-CSF and M-CSF cultured cells IFNg/LPS increased the expression of genes associated with M1 macrophages, e.g. CXCL10 and CCR7; while treatment with IL-4/IL-13 lead to an increase of M2 markers, Mannose Receptor and most prominent 15-Lipoxygenase. In addition, preliminary data also point to an involvement of histone modifying enzymes including MLL and KDM6B in the M1setting, whereas there was an association of DNA methyltransferase(s) like DNMT1 with the M2 phenotype. Overall, further analysis of the epigenetic mechanisms governing the M1/M2 phenotype will hopefully provide a better understanding of this important macrophage fate decision.

Phenotypic and epigenetic approach evaluating human M1 and M2 macrophages (167.9)